Attwood M, Griffin P, Noel AR, Albur M, et al. Antibacterial effect of seven days exposure to ceftolozane-tazobactam as monotherapy and in combination with fosfomycin or tobramycin against Pseudomonas aeruginosa with ceftolozane-tazobactam MICs at or above 4 mg/l in an in vitro pharmacokinetic mod J Antimicrob Chemother 2023;78:2254-2262.
PMID: 37527369